Is corton beneficial for pediatric patients with coryza undergoing anesthesia?
Phase 2
- Conditions
- Acute Nasopharyngitis.Coryza (acute)Nasal catarrh, acuteNasopharyngitis
- Registration Number
- IRCT201307023436N2
- Lead Sponsor
- Department of Anesthesiology,Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Inclusion:1- recent (started within two week) upper respiratory infection (URI).2- Mild URI (based on Parnis criteria). 3- anesthesia could not be postponed for 6 weeks later. 4- ASA class II
Exclusion: 1- Difficult airway. 2- Cardiac condition. 3- Drug allergy. 4- Change in surgery or anesthesia plan (more drug prescriptions other than protocol) 5- long lasting surgery (more than an hour)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cough. Timepoint: (after intervention) Recovery, and 7 days later. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method Desaturation (SPO2 less than 92%). Timepoint: (after intervention) Induction, Maintenance, Emergence and Recovery. Method of measurement: Continious pulse oximetry.;Partial Laryngospasm (inspiratory stidor). Timepoint: (after intervention) Induction, maintenance, Emergence and Recovery. Method of measurement: Continious observation.;Bronchospasm (expiratory wheeze). Timepoint: (after intervention) Induction, maintenance, emergence and recovery. Method of measurement: Lung auscultation.;Vomiting. Timepoint: (after intervention) Induction, maintenance, emergence and recovery. Method of measurement: Observation.;Re-admission within a week after discharge (respiratory related). Timepoint: (after intervention) 7 days after anesthesia. Method of measurement: Telephone asking.